Global Enzyme Replacement Therapy Market – Industry Trends and Forecast to 2028

Market Analysis and Insights : Global Enzyme Replacement Therapy Market

The enzyme replacement therapy market is expected to witness market growth at a rate of 6.75% in the forecast period of 2021 to 2028. Data Bridge Market Research report on enzyme replacement therapy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of enzyme replacement therapy market.

Enzyme replacement therapy refers to a medical therapy that is utilized for treating congenital enzyme deficiencies with the use of human and animal or recombinant engineered enzymes. The principle of ERT is defined as a replacement of artificial enzyme in people having enzyme deficiency. Oral and intravenous routes of administration are often used for ERT. Enzyme replacement therapies are generally applied in some lysosomal storage diseases such as Pompe disease, Gaucher disease, and Hurler syndrome among others.

The rise in prevalence of rare diseases across the globe acts as one of the major factors driving the growth of enzyme replacement therapy market. The increase in the demand for ERT to improve the treatment of rare diseases, and surge in government spending on healthcare infrastructure, such as favorable reimbursement for ERT, accelerate the market growth. The increase in adoption of enzyme replacement therapy (ERT) to replace specific defective enzymes in LSD patients with in vitro synthesized functional enzymes, and rise in availability of enzyme replacement therapies, further influence the market. Additionally, focus on importance of patient safety, increase in the population, growth of awareness, improved healthcare infrastructure, and less stringent guidelines for rare diseases positively affects the enzyme replacement therapy market. Furthermore, advancements in the therapy and government support for treatment extend profitable opportunity to the market players in the forecast period of 2021 to 2028.

On the other hand, availability of alternative therapies over enzyme replacement therapies and reimbursement issues in various countries are expected to obstruct the market growth. Lack of skilled professionals and concerns regarding side effects of therapy are projected to challenge the enzyme replacement therapy market in the forecast period of 2021-2028.

This enzyme replacement therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enzyme replacement therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Enzyme Replacement Therapy Market Scope and Market Size

The enzyme replacement therapy market is segmented on the basis of enzyme type, indication type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of enzyme type, the enzyme replacement therapy market is segmented into alglucerase alfa, imiglucerase, taliglucerase alfa, velaglucerase alfa and others.
• On the basis of indication type, the enzyme replacement therapy market is segmented into gaucher disease, fabry disease, pompe disease, hurler syndrome and others.
• On the basis of route of administration, the enzyme replacement therapy market is segmented into oral, injectable and others.
• On the basis of end users, the enzyme replacement therapy market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the enzyme replacement therapy market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Enzyme Replacement Therapy Market Country Level Analysis

The enzyme replacement therapy market is segmented on the basis of enzyme type, indication type, route of administration, end users and distribution channel.      

The countries covered in the enzyme replacement therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the enzyme replacement therapy market because of the well-developed healthcare infrastructure and the presence of key players within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the economically developing and the increase in disposable income in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The enzyme replacement therapy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Enzyme Replacement Therapy Market Share Analysis

The enzyme replacement therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to enzyme replacement therapy market.

The major players covered in the enzyme replacement therapy market report are CANbridge Life Sciences Ltd., Leadiant Biosciences, Inc., Sanofi, TEIJIN LIMITED, Avid Bioservices, Inc., SmartPharm Therapeutics, GREEN CROSS CORP, Pfizer Inc., GlaxoSmithKline plc., BioMarin, ALLERGAN, Alexion Pharmaceuticals, Inc., Horizon Therapeutics plc, Actelion Pharmaceuticals Ltd, Protalix Biotherapeutics, AbbVie Inc., Johnson & Johnson Services, Inc., Digestive Care, Inc., Takeda Pharmaceutical Company Limited, and Perseo Pharma AG, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-50213